Texas Launches Multimillion Dollar Campaign to Combat Vaccine Hesitancy

Registered nurse, Adele Prieto, left, receives her second dose of the COVID-19 vaccine from Lesia Turner at the Dallas County mass vaccination site at Fair Park Wednesday, Jan. 20, 2021, in Dallas.

Registered nurse, Adele Prieto, left, receives her second dose of the COVID-19 vaccine from Lesia Turner at the Dallas County mass vaccination site at Fair Park Wednesday, Jan. 20, 2021, in Dallas. AP Photo/LM Otero

 

Connecting state and local government leaders

Local governments and advocacy groups are targeting skeptical communities early, but the state is holding back a large media blitz until more vaccine arrives.

Snappy music opens the 15-second video featuring a diverse bunch of Texans getting their shots at a COVID-19 vaccination site.

The ad ends with a Black woman imploring her peers to “do it for yourself, do it for your family, do it for your community.”

Then she feigns shooting a basketball through a hoop with her hands.

“Take the shot!”

Another video released this week features vaccinated Texans over 65 talking about seeing their grandchildren again.

The ads, developed by the Texas Department of Health Services and released in the past week, are the first in a $2.3 million public awareness campaign being launched by the state to increase acceptance of the COVID-19 vaccine and inform the public on how to get the shot.

It comes amid fears that not enough people will choose to be vaccinated in order to stop the spread of the deadly virus, which has killed 39,000 Texans and which experts estimate can only be overcome if at least 75% of the population is immunized. National surveys indicate that as many as 40% of Americans are hesitant to get the shot, with those numbers disproportionately higher among communities of color.

Health experts and public officials widely agree that the vaccine is safe. Pfizer and Moderna reported their vaccines are 95% and 94% effective, respectively, at protecting people from serious illness, and while no vaccine is without side effects, clinical trials for both Pfizer and Moderna show serious reactions are rare.

Most of the state’s efforts, including TV, radio and print buys, are in development amid ongoing market research, but won’t be rolled out publicly until more vaccine supplies are available, state health officials said.

“At this point, the demand for vaccine is much greater than the supply,” said DSHS spokesperson Chris Van Deusen. “We’ll increase the resources we’re committing to promoting vaccination as the supply increases and as more people become eligible to be vaccinated.”

Early efforts in communities of color, which have been disproportionately affected by the virus but have less access to the vaccine than their white counterparts, are being led by some local governments and advocacy groups.

Harris County Judge Lina Hidalgo said “the bulk of our investments” in a new countywide awareness program are focused on the vaccine hesitancy issue due to high rates of skepticism in the state’s most populous county.

“Even as we wait for vaccine supplies to catch up, we can't wait on our work to get folks ready to go so they're registered for the waitlists and ready to get the vaccine as the supply chain catches up.”

The demand in Texas right now far outpaces supply, with upwards of 8 million Texans eligible for the injection but fewer than 3 million receiving at least one dose as of Feb. 10.

"Timing is a Really Big Challenge"

Texas health advocates say that while state officials are waiting for vaccine supply to increase, it’s a good idea to get widespread awareness programs ready to launch.

“Leaders in their awareness efforts need to be honest and acknowledge the fact that people are and will experience frustration as they try and access a vaccine,” said Rekha Lakshmanan, director of policy at The Immunization Partnership in Houston. “This is the reality. Hopefully, these challenges will be mitigated when more vaccines come online, but leaders need to use this time right now before mass vaccination begins to develop ... awareness programs.”

But starting more targeted awareness campaigns early is an important step toward achieving a higher level of acceptance and avoiding delays in getting the shot administered to a large number of people when it is finally available, said Kolina Koltai, who studies vaccine misinformation at the Center for an Informed Public at the University of Washington.

“The more vulnerable populations where there's higher rates of vaccine hesitancy, it definitely makes sense to target resources there,” Koltai said. “I would argue for sooner, rather than later. You want people to want to get it [the vaccine], even if it's not available yet.”

Molly Sauer, a research associate at Johns Hopkins Bloomberg School of Public Health, said a lack of continuity and consistent messaging from various levels of government can confuse residents who don’t know where to go for primary sources.

Meeting vaccine demand and spreading accurate information need to occur simultaneously, even if some states have delayed public messaging until now, she said.

“You’ve seen a lot of different approaches in different states,” Sauer said. “Some have tried to be really at the front, even if it meant they were getting ahead of some of the federal messaging. Others are playing catch up. Timing is a really big challenge.”

Texas’ rollout of its awareness campaign echoes the strategy of the Biden administration, which has delayed a planned vaccine-acceptance and awareness campaign until more shots become available.

Meanwhile, nongovernmental groups around the country are moving forward with targeted messaging. NBA Cares is featuring Black and Hispanic athletes, medical professionals and prominent figures in pro-vaccination TV spots and online videos.

And the Ad Council, whose national health campaigns helped increase widespread acceptance of the polio vaccine in the 1950s, has launched the COVID-19 Vaccine Education Initiative in partnership with the COVID Collaborative to combat vaccine hesitancy and created a toolkit for states and local community groups and governments to use for their own awareness campaigns.

The effort is focused on communities of color but will target a broader swath of the public as vaccine supplies grow.

A late December survey led by the Ad Council showed that public health officials were among the most trusted sources for vaccine information — while politicians were among the least trusted.

Across the country, campaigns in large states like California and New York have concentrated on vulnerable populations and focused their efforts largely on informing people about the vaccine, rather than targeting hesitancy specifically.

California’s Vaccinate All 58 program aims to reach all of California’s 58 counties with a focus on communities with limited access because of race, ethnicity or language barriers.

And cities from Nashville to New York City are ramping up their own messaging to encourage people to get the vaccine. In Florida, where the state-run awareness efforts largely focus on vaccine sites and availability, city officials in Miami have released public service announcements about the safety and necessity of the vaccine on YouTube and other social media, using public health figures and local officials to urge eligible residents to get their shots.

Texas Plans Statewide Media Blitz 

The state’s COVID-19 Vaccination Plan, released in October, says the state will focus mainly on educating the public about the importance and safety of the vaccine, how to obtain the shot and what to expect. The DSHS website has an FAQ and information about who is eligible and where vaccinations are available.

The state has already done some digital advertising to push the idea of vaccine safety and plans to use TV, radio, online and social media advertising, as well as outdoor advertising. A statewide media blitz planned for the months ahead will also target people in rural areas, another population that has shown higher hesitancy to the vaccine.

In addition to state efforts, a campaign initiated by the Texas AARP features a series of online question-and-answer sessions, called “Tele-Town Halls” to reduce hesitancy among older and more vulnerable residents, whose acceptance of the vaccine is especially critical to reduce deaths and hospitalization rates.

In Harris County, where more than two-thirds of residents are Black or Hispanic, Hidalgo said last week that hesitancy among those populations presents “a clear and present danger” to efforts to overcome the pandemic.

Commissioners there allocated $1 million — with flexibility to spend more — for its “Stay Smart, Do Your Part” campaign aimed at reticent communities.

The county is targeting ZIP codes where vaccine rates are low among people of color with ads in English and Spanish — along with an online toolkit for community groups in English, Spanish and Vietnamese.

There are also plans for outdoor advertising and partnerships with grassroots groups and other organizations to further spread the message to these populations, said Rafael Lemaitre, Hidalgo’s spokesperson.

“It's easy to get wrapped up in the short term media coverage about this sky high amount of demand with the relatively low amount of [vaccine] supply,” he said. “But we have to look around the corner and that's what we're doing with this campaign, because we know that the problem [of supply] can very easily and likely will be reversed.”

AARP has been a financial supporter of The Texas Tribune, a nonprofit, nonpartisan news organization that is funded in part by donations from members, foundations and corporate sponsors. Financial supporters play no role in the Tribune's journalism. Find a complete list of them here.

This article originally appeared in The Texas Tribune at https://www.texastribune.org/2021/02/12/Texas-campaign-vaccine-hesitancy/.

The Texas Tribune is a member-supported, nonpartisan newsroom informing and engaging Texans on state politics and policy. Learn more at texastribune.org.

Karen Brooks Harper is a reporter at The Texas Tribune. Marissa Martinez is a reporting fellow.

NEXT STORY: As Drug Prices Keep Rising, State Lawmakers Propose Tough New Bills to Curb Them

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.